首页> 外文会议>World congress of chemical engineering >Human Papillomavirus Type 16 Major Capsid ProteinL1 Vaccine Production From Inclusion Body Protein

【24h】

Human Papillomavirus Type 16 Major Capsid ProteinL1 Vaccine Production From Inclusion Body Protein

机译：人乳头瘤病毒16型主要衣壳蛋白L1包含体蛋白的疫苗生产

获取原文

页面导航

著录项
相似文献
相关主题

著录项

来源
《World congress of chemical engineering》|2001年|1-6|共6页
会议地点 Melbourne(AU)
作者
W. B. Lai; A. P. J. Middelberg;
展开▼
作者单位

Department of Chemical EngineeringUniversity of Cambridge New Museums Site Pembroke StreetCambridge CB2 3RA UK;

展开▼
会议组织
原文格式 PDF
正文语种
中图分类
关键词
入库时间 2022-08-26 14:39:18

相似文献

外文文献
中文文献
专利

1. Simultaneous quantification of major capsid protein of human papillomavirus 16 and human papillomavirus 18 in multivalent human papillomavirus vaccines by liquid chromatography-tandem mass spectrometry [J] . Journal of chromatography, A: Including electrophoresis and other separation methods . 2020,第期

机译：用液相色谱 - 串联质谱法同时定量人乳头瘤病毒16和人乳头瘤病毒18多价乳头瘤病毒疫苗中的人乳头瘤病毒18
2. Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization [J] . Ning Tingting, Wolfe Aaron, Nie Jianhui, The Journal of Infectious Diseases . 2017,第7期

机译：人乳头瘤病毒16型L1主要衣壳蛋白的自然发生的单氨基酸取代：对抗体介导的中和敏感性的改变
3. Production of human papillomavirus type 33 L1 major capsid protein and virus-like particles from Bacillus subtilis to develop a prophylactic vaccine against cervical cancer [J] . J.O. Baek, J.W. Seo, O. Kwon Enzyme and Microbial Technology . 2012,第3期

机译：从枯草芽孢杆菌生产人乳头瘤病毒33型L1主要衣壳蛋白和病毒样颗粒，以开发预防宫颈癌的疫苗
4. DIFFERENTIAL ANTIBODY RESPONSE AGAINST CONFORMATIONAL AND LINEAR EPITOPES OF THE L1 PROTEIN FROM HUMAN PAPILLOMAVIRUS TYPES 16/18 IS GENERATED IN VACCINATED WOMAN OR WITH DIFFERENT EXPOSURES TO THE VIRUS. [C] . Gutierrez-Xicotencatl L, Pedroza-Saavedra A, Rodriguez-Ocampo AN, Vaccine technology VI . 2016

机译：针对人乳头瘤病毒类型16/18的L1蛋白质的构象和线性表位产生的不同抗体反应是在疫苗接种的妇女中产生的，或在与病毒的不同接触中产生的。
5. Mutational analysis of the E5 protein of human papillomavirus type 16 to analyze the role of interaction with the 16-kDa subunit of the vacuolar H(+)-ATPase in inhibiting activity of this complex and altering metabolism of the epidermal growth factor receptor. [D] . Adam, Jamie L. 2000

机译：人类乳头瘤病毒16型E5蛋白的突变分析，以分析与液泡H（+）-ATPase的16-kDa亚基相互作用在抑制该复合物活性和改变表皮生长因子受体代谢中的作用。
6. Thiol-reactive reagents inhibits intracellular trafficking of human papillomavirus type 16 pseudovirions by binding to cysteine residues of major capsid protein L1 [O] . Yoshiyuki Ishii, Kazunari Kondo, Tamae Matsumoto, 2007

机译：硫醇反应试剂通过结合主要衣壳蛋白L1的半胱氨酸残基抑制人乳头瘤病毒16型假病毒颗粒的细胞内运输
7. Naturally Occurring Single Amino Acid Substitution in the L1 Major Capsid Protein of Human Papillomavirus Type 16: Alteration of Susceptibility to Antibody-Mediated Neutralization [O] . Tingting Ning, Aaron Wolfe, Jianhui Nie, 2017

机译：人乳头瘤病毒16型L1主要衣壳蛋白的自然发生的单氨基酸取代：对抗体介导的中和敏感性的改变

Human Papillomavirus Type 16 Major Capsid ProteinL1 Vaccine Production From Inclusion Body Protein

著录项

相似文献

相关主题

期刊订阅